Altre lingue Revvity, Inc.

Azioni

RVTY

US7140461093

Tempo differito Nyse Altri mercati azionari 19:00:01 03/07/2024			Variaz. 5gg	Var. 1 gen.
102,6 ^USD	+0,54%		-1,69%	-6,18%

20/06	Bionano Genomics dice a Revvity di commercializzare il software VIA	MT
20/06	Bionano Genomics, Inc. annuncia un accordo di marketing software con Revvity, Inc. per la ricerca sul sequenziamento dei neonati	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Bionano Genomics Says Revvity to Commercialize VIA Software	20/06
Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research	20/06
Bionano Genomics, Inc. Announces Software Marketing Agreement with Revvity, Inc. for Newborn Sequencing Research	20/06
GenKOre Announces Strategic Collaboration with Revvity to Develop Innovative Gene Therapy Treatments	18/06
Revvity to Present at Goldman Sachs Global Healthcare Conference	28/05
Revvity : Q1 2024 Earnings Transcript	30/04
Revvity beats quarterly estimates on demand for diagnostic equipment	29/04
Revvity Q1 Adjusted Earnings, Revenue Down; Lowers 2024 Revenue Guidance	29/04
Earnings Flash (RVTY) REVVITY Reports Q1 Revenue $649.9M, vs. Street Est of $647.5M	29/04
Revvity: Q1 Earnings Snapshot	29/04
Earnings Flash (RVTY) REVVITY Posts Q1 EPS $0.98, vs. Street Est of $0.94	29/04
Revvity Announces Financial Results for the First Quarter of 2024	29/04
Revvity, Inc. Updates Earnings Guidance for the Full Year 2024	29/04
Revvity, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Revvity Board Declares Quarterly Dividend	25/04
Revvity, Inc. Declares Quarterly Dividend, Payable on August 9, 2024	25/04
Revvity’s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings	25/04
Revvity to Present at BofA Securities 2024 Health Care Conference	25/04
Early Check Newborn Screening Study Taps Revvity to Provide Genome Sequencing	25/04
Declaration of Voting Results by Revvity, Inc	24/04

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Revvity, Inc.

Azioni

RVTY

US7140461093

Altre lingue

Filtri